ES2060628T3 - Acidos oxapenem-3-carboxilicos estables. - Google Patents

Acidos oxapenem-3-carboxilicos estables.

Info

Publication number
ES2060628T3
ES2060628T3 ES88111670T ES88111670T ES2060628T3 ES 2060628 T3 ES2060628 T3 ES 2060628T3 ES 88111670 T ES88111670 T ES 88111670T ES 88111670 T ES88111670 T ES 88111670T ES 2060628 T3 ES2060628 T3 ES 2060628T3
Authority
ES
Spain
Prior art keywords
carbon
pharmaceutically acceptable
bonded
single bonds
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88111670T
Other languages
English (en)
Inventor
Hans Rudolf Prof Dr Pfandler
Wolfram Dr Hendel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2060628T3 publication Critical patent/ES2060628T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

COMBINACIONES DE LAS FORMULAS DE ESTRUCTURA (I) Y SUS SALES, ESTERES Y DERIVADOS A AMIDOS ADMISIBLES PARA LA FARMACIA DONDE R1 Y R2 INDEPENDIENTES UNO DEL OTRO REPRESENTAN HIDROGENO O GRUPOS ADMISIBLES PARA LA FARMACIA CON 1 A 10 ATOMOS DE CARBONO QUE ESTAN UNIDOS A LA OTRA PARTE DE LA MOLECULA MEDIANTE COMBINACIONES SIMPLES CARBONO - CARBONO DE LOS GRUPOS R3, R4 Y R5 UNIDOS LLEVA A UN AUMENTO IMPORTANTE DE LA ESTABILIDAD HIDROLITICA Y ASI DEL EFECTO ANTIBACTERIAL DE LOS ACIDOS OXAPENEM - CARBONO.
ES88111670T 1987-07-31 1988-07-20 Acidos oxapenem-3-carboxilicos estables. Expired - Lifetime ES2060628T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873725375 DE3725375A1 (de) 1987-07-31 1987-07-31 Stabile oxapenem-3-carbonsaeuren

Publications (1)

Publication Number Publication Date
ES2060628T3 true ES2060628T3 (es) 1994-12-01

Family

ID=6332772

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88111670T Expired - Lifetime ES2060628T3 (es) 1987-07-31 1988-07-20 Acidos oxapenem-3-carboxilicos estables.

Country Status (20)

Country Link
US (1) US5096899A (es)
EP (1) EP0301394B1 (es)
JP (1) JPH0819135B2 (es)
KR (1) KR890002169A (es)
CN (1) CN1031533A (es)
AT (1) ATE95521T1 (es)
AU (1) AU618013B2 (es)
CA (1) CA1339450C (es)
DD (1) DD282012A5 (es)
DE (2) DE3725375A1 (es)
DK (1) DK425888A (es)
ES (1) ES2060628T3 (es)
FI (1) FI883553A (es)
HU (1) HU203355B (es)
IE (1) IE63026B1 (es)
IL (1) IL87254A (es)
NO (1) NO883188L (es)
PH (1) PH27226A (es)
PT (1) PT88118B (es)
ZA (1) ZA885571B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3833693A1 (de) * 1988-10-04 1990-04-05 Bayer Ag Stabile oxapenem-3-carbonsaeuren und ihre verwendung als ss-lactamasehemmer
DE4027928A1 (de) * 1990-09-04 1992-03-05 Bayer Ag Neue 2-tert.substituierte methyl-oxapenem-3-carbonsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung
DE4142423A1 (de) * 1991-12-20 1993-06-24 Pfaendler Hans Rudolf ((ls)-hydroxyalkyl)oxapenem-3-carbonsaeuren und ihre verwendung als betalactamasehemmer
EP1199077A1 (en) * 2000-10-19 2002-04-24 Amura Limited Stable compositions of oxapenem-3-carboxylic acids by Co-lyophilisation with pharmaceutical carriers
BR0114762A (pt) * 2000-10-19 2003-10-07 Amura Ltd Composições farmacêuticas contendo ácidos oxapenem-3-carboxìlicos
GB2369358A (en) * 2000-10-19 2002-05-29 Amura Ltd Oxapenems and pharmaceutical compositions thereof
GB0106428D0 (en) * 2001-03-15 2001-05-02 Amura Ltd Antibacterial composition
AR039475A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
AR039774A1 (es) * 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
US8415339B2 (en) 2007-05-21 2013-04-09 Hans Rudolf Pfaendler Bactericidal anti-MRSA active pharmaceutical composition containing carbapenems
WO2009089380A2 (en) * 2008-01-08 2009-07-16 The Trustees Of Columbia University In The City Of New York Methods for p2ry5 mediated regulation of hair growth and mutants thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1368236A (en) * 1970-11-03 1974-09-25 Glaxo Lab Ltd Azetidinone derivatives and their preparation
AU498131B2 (en) * 1974-02-26 1979-02-15 Ciba-Geigy Ag Production of cephems by cyclization
NZ177159A (en) * 1974-04-20 1978-03-06 Beecham Group Ltd Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions
CA1136132A (en) * 1975-02-17 1982-11-23 Teruji Tsuji Cyclization to form cephem ring and intermediates therefor
US4147864A (en) * 1975-02-20 1979-04-03 Ciba-Geigy Corporation Process for the manufacture of 7β-amino-3-cephem-3-ol-4 carboxylic acid compounds
US4024152A (en) * 1975-09-19 1977-05-17 Eli Lilly And Company 4-Dithio-3-imido-azetidin-2-ones
GB1529913A (en) * 1976-02-04 1978-10-25 Beecham Group Ltd Beta-lactam compounds
GB1591438A (en) * 1976-09-09 1981-06-24 Glaxo Lab Ltd Clavem derivatives
DE2740527A1 (de) * 1976-09-09 1978-03-16 Glaxo Lab Ltd Clavulansaeureabkoemmlinge und deren herstellung
GB1593275A (en) * 1976-10-22 1981-07-15 Glaxo Lab Ltd Clavam derivatives
NO771106L (no) * 1977-03-10 1978-09-12 Beecham Group Ltd Fremgangsmaate for fremstilling av etere
US4260627A (en) * 1978-10-24 1981-04-07 Merck & Co., Inc. 1-, 6- And 2-substituted-1-carba-2-penem-3-carboxylic acids
GB2045236A (en) * 1979-03-26 1980-10-29 Hoechst Uk Ltd Oxapenem derivatives

Also Published As

Publication number Publication date
EP0301394A1 (de) 1989-02-01
EP0301394B1 (de) 1993-10-06
DK425888D0 (da) 1988-07-29
CA1339450C (en) 1997-09-09
PH27226A (en) 1993-05-04
CN1031533A (zh) 1989-03-08
HU203355B (en) 1991-07-29
ATE95521T1 (de) 1993-10-15
FI883553A (fi) 1989-02-01
IL87254A0 (en) 1988-12-30
IL87254A (en) 1993-01-31
AU618013B2 (en) 1991-12-12
ZA885571B (en) 1989-04-26
NO883188L (no) 1989-02-01
AU2004088A (en) 1989-02-02
JPS6442484A (en) 1989-02-14
PT88118B (pt) 1995-03-01
DD282012A5 (de) 1990-08-29
HUT48889A (en) 1989-07-28
KR890002169A (ko) 1989-04-08
FI883553A0 (fi) 1988-07-28
DE3884705D1 (de) 1993-11-11
DK425888A (da) 1989-02-01
PT88118A (pt) 1989-06-30
NO883188D0 (no) 1988-07-18
IE882347L (en) 1989-01-31
DE3725375A1 (de) 1989-02-09
IE63026B1 (en) 1995-03-22
US5096899A (en) 1992-03-17
JPH0819135B2 (ja) 1996-02-28

Similar Documents

Publication Publication Date Title
FI915136A (fi) Cykliska iminoderivat, dessa foereningar innehaollande laekemede och foerfarande foer deras framstaellning.
FI874570A0 (fi) Antibakteriska medel -ii.
PT98006A (pt) Processo para a preparacao de novos derivados peptidicos
FI102069B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmistamiseksi
ATE100123T1 (de) Stabilisieren von unter abspaltung von alkoholen zu elastomeren vernetzaren organopolysiloxanmassen.
ES2060628T3 (es) Acidos oxapenem-3-carboxilicos estables.
FI904850A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 24-homo-D-vitamiinijohdannaisten valmistamiseksi
FR2649110B1 (fr) Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2620699B1 (fr) Procede de synthese d'alpha amino acides n alkyles et de leurs esters. application a la synthese de carboxyalkyl dipeptides
FI863311A (fi) Farmaceutiska kompositioner innehaollande acylerade fosfolipider.
ATE54148T1 (de) Neue cephalosporine und verfahren zu ihrer herstellung.
AU5455780A (en) Hexahydro-1,4-oxazepines
ES2077345T3 (es) Intermediarios del grupo mureidomicina, su preparacion y su uso.
DE69108580D1 (de) Optisch aktives Derivat der d-2-(6-Methoxy-2-naphthyl)-propionsäure und es enthaltende pharmazeutische Zusammensetzungen.
ES2087421T3 (es) Acidos (1's)-hidroxialquiloxapenem-3-carboxilicos y su uso como inhibidor de la betalactamasa.
FR2608606B1 (fr) Derives d'acide dibenzo(be)oxepinne-acetique, leur preparation et leur application en therapeutique
FI943596A (fi) Menetelmä terapeuttisesti käytt¦kelpoisten makrolidiyhdisteiden valmistamiseksi

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 301394

Country of ref document: ES